MedTrace Logo

Impact of Mulberry Leaf on Type 2 Diabetes

NCT00795704 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2012-08-09

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate whether mulberry leaf extract will help control blood sugar in patients with type 2 diabetes. We also want to look at the safety of mulberry leaf extract in these patients.

Conditions

Interventions

DRUG

Mulberry Leaf Extract

Mulberry Leaf Extract 1000 mg by mouth three times daily for 3 months

DRUG

Placebo

Placebo 500 mg #2 capsules by mouth three times daily

Sponsors & Collaborators

  • University of Mississippi Medical Center

    lead OTHER

Principal Investigators

  • Daniel M Riche, Pharm.D. · University of Mississippi Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2010-05-31
Completion
2010-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00795704 on ClinicalTrials.gov